Hormone Receptor Negative Breast Carcinoma Clinical Trials

8 clinical trials for Hormone Receptor Negative Breast Carcinoma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies — RECRUITING · PHASE2
• Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer — RECRUITING · NA
• ETHAN - ET for Male BC — RECRUITING · PHASE2
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• PRE-I-SPY Phase I/Ib Oncology Platform Program — RECRUITING · PHASE1
• Onvansertib + Paclitaxel In TNBC — ACTIVE_NOT_RECRUITING · PHASE1
• A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer — WITHDRAWN · PHASE1

Refine this search